iCRT14
SIGMA/SML0203 - ≥98% (HPLC)
Synonym: 5-
CAS Number: 677331-12-3
Empirical Formula (Hill Notation): C21H17N3O2S
Molecular Weight: 375.44
MDL Number: MFCD04366833
Linear Formula: C21H17N3O2S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow to orange |
| form | powder |
| InChI | 1S/C21H17N3O2S/c1-14-11-1 |
| InChI key | NCSHZXNGQYSKLR-UNOMPAQXSA |
| Quality Level | 100 ![]() |
| SMILES string | Cc1cc(C=C2/SC(=O)N(c3ccc |
| solubility | DMSO: ≥10 mg/mL |
| storage temp. | 2-8°C |
| Application: | iCRT14 may be used in Wnt /β-catenin-mediated cell signaling studies. |
| Biochem/physiol Actions: | iCRT14 belongs to the thiazolidinedione class of β-catenin-responsive transcription inhibitors. It decreases the levels of Dishevelled protein and modulates the binding of T-cell factor (TCF) to DNA. It results in consistent decrease in reduction of cell proliferation and tumor growth in colon cancer cells. |
| Biochem/physiol Actions: | iCRT14 is a Wnt / β-catenin pathway inhibitor. It is a potent inhibitor of Catenin Responsive Transcription (CRT) reporter genes, as well as endogenous gene targets. iCRT14 also disrupts β-catenin-TCF4 interaction in a dose dependent manner, and causes G0/G1 arrest in colon tumor lines. |
| Biochem/physiol Actions: | Wnt / beta-catenin pathway inhibitor |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

